Synthesized peptide derived from internal of human RSAD1.
- Extracts from HeLa cells and human breast carcinoma tissue
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid repeated freeze / thaw cycles.
Preservative: 0.02% Sodium Azide
Constituents: 50% Glycerol, PBS (without Mg2+ and Ca2+), 150mM Sodium chloride, pH 7.4
Concentration information loading...
Immunogen affinity purified
Our Abpromise guarantee covers the use of
in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
IHC-P: 1/50 - 1/100.
WB: 1/500 - 1/1000. Predicted molecular weight: 49 kDa.
Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.
Anti-RSAD1 antibody 图像
Western blot - RSAD1 antibody (ab92905)
All lanes : Anti-RSAD1 antibody (ab92905) at 1/500 dilution
Lane 1 : Extracts from HeLa cells
Lane 2 : Extracts from HeLa cells with immunising peptide at 10 µg
Lysates/proteins at 30 µg per lane.
Predicted band size : 49 kDa
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - RSAD1 antibody (ab92905)
Immunohistochemistry analysis of paraffin-embedded
human breast carcinoma tissue with (+) and without (-) immunising peptide, using ab92905 at 1/50-1/100 dilution.
Anti-RSAD1 antibody (ab92905)参考文献
has not yet been referenced specifically in any publications.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"